Despegar.com (NYSE: DESP), our latest portfolio addition, is a leading Spanish language online travel agency, headquartered in Argentina. It has been nicknamed as the “Expedia of Latin America.” Expedia also owns roughly 14% of Despegar and has been speculated as a potential buyer of the company. Although Despegar, whose name… Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
Yesterday, TAL Education (NYSE: TAL) delivered an earnings beat and the share price took off. The stock gained 17.7% for the day. The share price had marched downward in the days leading up to the earnings release. Some investors worried about disappointment. However, TAL’s results showed the worries were overblown. Read More
Buy Despegar.com, Corp. (NYSE: DESP). Today we add to our portfolio a stock that has been on our watch list. Tiger Global Management, one of our favorite funds to follow, was already a major owner when Despegar.com (NYSE: DESP) was still a private company. The company IPO’ed four months ago,… Read More
Master Limited Partnerships have been popular income investments for a long time. Lately they have fallen out of investors' favor. We take a look at some pros and cons of owning MLPs. Read More
Synchrony Financial (NYSE: SYF) reported fourth-quarter results on Friday morning and the stock gained about 3%. The share price had declined a little in recent days, probably due to investor concern that the company may announce some credit-deterioration news, which could lead to a sharp price drop after. They remember… Read More
The IRS requires you to take money from tax-deferred investment accounts once you turn a certain age. We discuss reasons why you may want to take the money early or late in the year. Read More
Jazz Pharmaceuticals (NASDAQ: JAZZ) has finally caught some positive momentum, gaining about 10% during the week. CEO Bruce Cozadd gave a strong presentation at the annual J.P. Morgan Healthcare Conference, which helped to awaken buying interest in the stock. Good Results Confirmed Jazz confirmed its 2017 revenue guidance, expected to… Read More
The sales launch of legal marijuana in California has sent related stocks flying, but investors should be careful. Rather than bet on one or two companies, it may be better to do this. Read More
Yesterday AngioDynamics (NASDAQ: ANGO) reported earnings (adjusted for one-time gains and losses) of $0.16 per share for its second fiscal quarter ended on November 30, 2016. The result missed analysts’ consensus expectation of $0.17 per share. Revenue also missed expectation: $86.7 million versus the $87.8 million expected. Due to the… Read More
These two companies enjoy leadership and strong execution in industries with sustainable demand growth. Their stocks have stalled a little lately but both should regain momentum in 2018. Read More